Sepsis is a medical emergency that depicts the body’s systemic immune reaction to an infectious process that could result in organ dysfunction and death. Early sepsis pathogen identification and early delivery of antimicrobial therapy result in better clinical outcomes for patients diagnosed with sepsis and septic shock. Method: Systematic reviews and meta-analyses that discussed sepsis pathogen identification, antibiotic resistance and timing in the treatment of sepsis were taken into account irrespective of the approach of the included studies, quantitative or qualitative. This literature review gathers data from twelve primary studies to perform a systematic review and evaluate existing empirical antibiotic therapies in order to treat the various degrees of sepsis and minimize antibiotic resistance. The remaining reviews, case studies, etc., were used as supplementary references. The studies compiled data from laboratory tests including lactate levels, fluid resuscitation, and diagnostic diagnostics like the SOFA score. Results: This paper identifies multiple factors that must be taken into account when treating individuals with sepsis. Prior to the administration of broad-spectrum empiric antibiotics, the severity and morbidity of the disease must be addressed. Excessive antibiotic usage has been associated with increased sepsis hospitalized mortality rates, and thus it is crucial to minimize antibiotic misuse in non-septic patients. This can be accomplished by differentiating between Gram-negative and Gram-positive bacteria, the purpose of biomarkers and identifying the antibiotic resistance pathway. Many patients from low economic statuses may experience difficulties accessing healthcare services and resources for sepsis treatment when diagnosed with sepsis. Additionally, through educational efforts, promoting awareness of sepsis and the relevance of timing in sepsis therapy can help dispel misconceptions about the illness and minimize sepsis patients from receiving insufficient care.
References
[1]
Karnatovskaia, V.L. and Festic, E. (2012) Sepsis: A Review for the Neurohospitalist. The Neurohospitalist, 2, 144-153. https://doi.org/10.1177/1941874412453338
[2]
Mayer, F.B., Yende, S. and Angus, D.C. (2014) Epidemiology of Severe Sepsis. Virulence, 5, 4-11. https://doi.org/10.4161/viru.27372
[3]
Fair, R.J. and Tor, Y. (2014) Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in Medicinal Chemistry, 6, 25-64. https://doi.org/10.4137/PMC.S14459
[4]
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E. and Leibovici, L. (2010) Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis. Antimicrobial Agents and Chemotherapy, 54, 4851-4863. https://doi.org/10.1128/AAC.00627-10
[5]
Busch, M.L. and Kadri, S.S. (2020) Antimicrobial Treatment Duration in Sepsis and Serious Infections. The Journal of Infectious Diseases, 222, S142-S155. https://doi.org/10.1093/infdis/jiaa247
[6]
D’Costa, V.M., King, C.E., Kalan L, Morar, M., Sung, W.W., Schwarz, C., Froese D, Zazula, G., Calmels F, Debruyne, R., Golding, G.B., Poinar, H.N. and Wright, G.D. (2011) Antibiotic Resistance Is Ancient. Nature, 477, 457-461. https://doi.org/10.1038/nature10388
[7]
Felden, B. and Cattoir, V. (2018) Bacterial Adaptation to Antibiotics through Regulatory RNAs. Antimicrobial Agents and Chemotherapy, 62, Article ID: e02503-17. https://doi.org/10.1128/AAC.02503-17
[8]
Davies, J. and Davies, D. (2010) Origins and Evolution of Antibiotic Resistance. Microbiology and Molecular Biology Reviews, 74, 417-433. https://doi.org/10.1128/MMBR.00016-10
[9]
Silhavy, T.J., Kahne, D. and Walker, S. (2010) The Bacterial Cell Envelope. Cold Spring Harbor Perspectives in Biology, 2, Article ID: a000414. https://doi.org/10.1101/cshperspect.a000414
[10]
Martin, G.S., Mannino, D.M., Eaton, S. and Moss, M. (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. The New England Journal of Medicine, 348, 1546-1554. https://doi.org/10.1056/NEJMoa022139
[11]
Ramachandran, G. (2014) Gram-Positive and Gram-Negative Bacterial Toxins in Sepsis: A Brief Review. Virulence, 5, 213-218. https://doi.org/10.4161/viru.27024
[12]
Landesman, H.S. and Gorbach, L.S. (1978) Gram Negative Sepsis and Shock. Orthopedic Clinics of North America, 9, 611-625. https://doi.org/10.1016/S0030-5898(20)30596-4
[13]
Chakraborty, K.R. and Burns, B. (2021) Statpearls: Systemic Inflammatory Response Syndrome. Statpearls Publishing, Treasure Island.
[14]
Breijyeh, Z., Jubeh, B. and Karaman, R. (2020) Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules, 25, Article No. 1340. https://doi.org/10.3390/molecules25061340
[15]
Marik, E.P. and Taeb, M.A. (2017) SIRS, qSOFA and New Sepsis Definition. Journal of Thoracic Disease, 9, 943-945. https://doi.org/10.21037/jtd.2017.03.125
[16]
Kievlan, D.R., Zhang, L.A., Chang, C.H., Angus, D.C. and Seymour, C.W. (2018) Evaluation of Repeated Quick Sepsis-Related Organ Failure Assessment Measurements among Patients with Suspected Infection. Critical Care Medicine, 46, 1906-1913. https://doi.org/10.1097/CCM.0000000000003360
[17]
Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, M.T., Townsend, S., Dellinger, P.R., Artigas, A., Schorr, C. and Levy, M.M. (2014) Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock from the First Hour: Results from a Guideline-Based Performance Improvement Program. Critical Care Medicine, 42, 1749-1755. https://doi.org/10.1097/CCM.0000000000000330
[18]
Rhee, C., Kadri, S.S., Dekker, P.J., Danner, L.R., Chen, H., Fram, D., Zhang, F., Wang, R. and Klompas, M. (2020) Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Network Open, 3, Article ID: e202899. https://doi.org/10.1001/jamanetworkopen.2020.2899
[19]
Ferrer, R., Martinez, L.M., Goma, G., Suarez, D., Alvarez-Rocha, L., Victoria de la Torre, M., Gonzalez, G., Zaragoza, R., Borges, M., Blanco, J., Herrejon, P.E. and Artigas, A. (2018) Improved Empirical Antibiotic Treatment of Sepsis after an Educational Intervention: The ABISS-Edusepsis Study. Critical Care Medicine, 22, Article No. 167. https://doi.org/10.1186/s13054-018-2091-0
[20]
Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., Gurka, D., Kumar, A. and Cheang, M. (2006) Duration of Hypotension before Initiation of Effective Antimicrobial Therapy Is the Critical Determinant of Survival in Human Septic Shock. Critical Care Medicine, 34, 1589-1596. https://doi.org/10.1097/01.CCM.0000217961.75225.E9
[21]
van Zanten, A.R., Brinkman, S., Arbous, M.S., Abu-Hanna, A., Levy, M.M., de Keizer, N.F. and Netherlands Patient Safety Agency Sepsis Expert Group (2014) Guideline Bundles Adherence and Mortality in Severe Sepsis and Septic Shock. Critical Care Medicine, 42, 1890-1898. https://doi.org/10.1097/CCM.0000000000000297
[22]
Colgan, R., Williams, M. and Johnson, J.R. (2011) Diagnosis and Treatment of Acute Pyelonephritis in Women. American Family Physician, 84, 519-526. https://doi.org/10.1186/s13054-021-03736-w
[23]
Niederman, M.S., Baron, R.M., Bouadma, L., Calandra, T., Daneman, N., DeWaele, J., Kollef, M.H., Lipman, J. and Nair, G.B. (2021) Initial Antimicrobial Management of Sepsis. Critical Care, 25, Article No. 307. https://doi.org/10.1016/j.ijantimicag.2020.106059
[24]
Thorsted, A., Nielsen, E.I. and Friberg, L.E. (2020) Pharmacodynamics of Immune Response Biomarkers of Interest for Evaluation of Treatment Effects in Bacterial Infections. International Journal of Antimicrobial Agents, 56, Article ID: 106059. https://doi.org/10.1136/bmj.j3418
[25]
Llewelyn, M.J., Fitzpatrick, J.M., Darwin, E., Tonkin-Crine, S., Gorton, C., Paul, J., et al. (2017) The Antibiotic Course Has Had Its Day. BMJ, 358, j3418. https://doi.org/10.1056/NEJMp1400276
[26]
Rhee, C., Gohil, S. and Klompas, M. (2014) Regulatory Mandates for Sepsis Care— Reasons for Caution. The New England Journal of Medicine, 370, 1673-1676. https://doi.org/10.1197/j.aem.2007.01.022
[27]
Pines, M.J., Hollander, E.J., Lee, H., Everett, W.W., Usher-Pines, L. and Metlay, P.J. (2007) Emergency Department Operational Changes in Response to Pay-for-Performance and Antibiotic Timing in Pneumonia. Academic Emergency Medicine, 14, 545-548.
[28]
Galiatsatos, P., Littleton, K., Pietri, J., Grant, M., Brigham, E. and Chen, E.S. (2017) C23 Critical Care: What Can Be Measured Can Be Improved—Investigating the Epidemiology and Outcomes of Patients with Acute Critical Illness: The Effect of Neighborhood Socioeconomic Status on Sepsis-Attributable Mortality. American Journal of Respiratory and Critical Care Medicine, 195, 1. https://www.proquest.com/scholarly-journals/c23-critical-care-what-can-be-measured-improved/docview/1926857698/se-2?accountid=14701
[29]
Galiatsatos, P., Follin, A., Alghanim, F., Sherry, M., Sylvester, C., Daniel, Y., Chanmugam, A., Townsend, J., Saria, S., Kind, A.J. and Chen, E. (2020) The Association between Neighborhood Socioeconomic Disadvantage and Readmissions for Patients Hospitalized With Sepsis. Critical Care Medicine, 48, 808-814. https://doi.org/10.1097/CCM.0000000000004307
[30]
O’Brien Jr., J.M., Lu, B., Ali, N.A., Levine, D.A., Aberegg, S.K. and Lemeshow, S. (2011) Insurance Type and Sepsis-Associated Hospitalizations and Sepsis-Associated Mortality among US Adults: A Retrospective Cohort Study. Critical care, 15, Article No. R130. https://doi.org/10.1186/cc10243
[31]
Donnelly, J.P., Lakkur, S., Judd, S.E., Levitan, E.B., Griffin, R., Howard, G., et al. (2018) Association of Neighborhood Socioeconomic Status with Risk of Infection and Sepsis. Clinical Infectious Diseases, 66, 1940-1947. https://doi.org/10.1093/cid/cix1109
[32]
Pop-Vicas, A. and Opal, S.M. (2014) The Clinical Impact of Multidrug-Resistant Gram-Negative Bacilli in the Management of Septic Shock. Virulence, 5, 206-212. https://doi.org/10.4161/viru.26210
[33]
Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B., Scheld, M., Spellberg, B. and Bartlett, J. (2009) Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases, 48, 1-12. https://doi.org/10.1086/595011
[34]
Johnson, J.R., Johnston, B., Clabots, C., Kuskowski, M.A. and Castanheira, M. (2010) Escherichia coli Sequence Type ST131 is the Major Cause of Serious multIdrug-Resistant, E. coli Infections in the United States. Clinical Infectious Diseases, 51, 286-294. https://doi.org/10.1086/653932
[35]
Bonomo, A.R. and Szabo, D. (2006) Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa. Clinical Infectious Diseases, 43, S49-S56. https://doi.org/10.1086/504477
[36]
Logan, L.K. (2012) Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in Children. Clinical Infectious Diseases, 55, 852-859. https://doi.org/10.1093/cid/cis543
[37]
Galiatsatos, P., Brigham, E.P., Pietri, J., Littleton, K., Hwang, S., Grant, M.C., Hansel, N.N. and Chen, E.S. (2018) The Effect of Community Socioeconomic Status on Sepsis-Attributable Mortality. Journal of Critical Care, 46, 129-133. https://doi.org/10.1016/j.jcrc.2018.01.008
[38]
Karakike, E., Kyriazopoulou, E., Tsangaris, I., Routsi, C., Vincent, J.L. and Giamarellos-Bourboulis, E.J. (2019) The Early Change of SOFA Score as a Prognostic Marker of 28-Day Sepsis Mortality: Analysis through a Derivation and a Validation Cohort. Critical Care, 23, Article No. 387. https://doi.org/10.1186/s13054-019-2665-5
[39]
See, I., Mu, Y., Cohen, J., Beldavs, Z.G., Winston, L.G., Dumyati, G., Holzbauer, S., Dunn, J., Farley, M.M., Lyons, C., Johnston, H., Phipps, E., Perlmutter, R. and erson, L., Gerding, D.N. and Lessa, F.C. (2014) NAP1 Strain Type Predicts Outcomes from Clostridium Difficile Infection. Clinical Infectious Diseases, 58, 1394-1400. https://doi.org/10.1093/cid/ciu125
[40]
Khanafer, N., Vanhems, P., Barbut, F., Luxemburger, C. and CDI01 Study Group (2017) Factors Associated with Clostridium Difficile Infection: A Nested Case-Control Study in a Three Year Prospective Cohort. Anaerobe, 44, 117-123. https://doi.org/10.1016/j.anaerobe.2017.03.003
